Terumo BCT, Inc.

About Terumo BCT, Inc.

Terumo BCT, Inc. is a global leader in blood component and therapeutic apheresis technologies, dedicated to enhancing patient care through innovative medical solutions. Established with a vision to improve the quality of life for patients worldwide, the company focuses on developing advanced technologies that facilitate safe and efficient blood collection, processing, and transfusion.

With a commitment to research and development, Terumo BCT invests significantly in creating cutting-edge products that meet the evolving needs of healthcare providers. Their extensive portfolio includes a range of devices and systems designed for blood banks, hospitals, and clinics, ensuring optimal outcomes for both patients and healthcare professionals.

Terumo BCT operates in over 130 countries, providing comprehensive support and training to its customers. The company prides itself on its strong partnerships with healthcare institutions, working collaboratively to enhance blood management practices and improve patient safety.

In addition to its focus on technology, Terumo BCT is committed to sustainability and corporate social responsibility. The company actively engages in initiatives that promote environmental stewardship and community health, reflecting its dedication to making a positive impact beyond the healthcare sector.

As part of the Terumo Corporation, Terumo BCT benefits from a rich heritage of innovation and excellence in the medical field. The company’s mission is to empower healthcare professionals with the tools they need to provide the best possible care, ultimately improving patient outcomes and saving lives.

• Core Activities: Blood component collection, therapeutic apheresis, and blood management solutions.
• Vision: To enhance patient care through innovative medical technologies.
• Global Reach: Operations in over 130 countries.